07:00 , Jul 12, 2010 |  BioCentury  |  Finance

Patient for Poxel

Patient for Poxel After the 2007 merger between Merck KGaA and Serono S.A. , some of the metabolic assets that were no longer a focus of the combined company were spun out into Poxel S.A....
00:06 , Jul 9, 2010 |  BC Extra  |  Financial News

Poxel raises EUR 16 million

Poxel S.A. (Lyon, France) raised EUR 16 million ($20.1 million) in a series A round led by Edmond de Rothschild Investment Partners. InnoBio Fund and Credit Agricole also participated. InnoBio is a venture fund managed...
07:00 , Jun 14, 2010 |  BC Week In Review  |  Financial News

Cytheris completes venture financing

Cytheris S.A. , Paris, France   Business: Infectious, Cancer   Date completed: 6/7/10   Type: Venture financing   Raised: E12 million ($14.3 million)   Investors: CDC Entreprises; Bioam Gestion; Caisse de Depot et Placement du...
02:10 , Mar 10, 2010 |  BC Extra  |  Financial News

BT Pharma raises EUR 13.1 million

BT Pharma S.A. (Labege, France) raised EUR 13.1 million ($17.8 million) in a series B round led by new investor AGF. Additional new investors Institut Regional de Developpement Industriel; Amundi Private Equity Funds; and InnoBio...
07:00 , Mar 24, 2008 |  BioCentury  |  Finance

Nomura's investments

Nomura's investments Nomura's investments Nomura Phase4 Ventures has invested in at least 25 biotechs since 1999. Usually Nomura's contribution for an initial investment will be some $15-$25 million of the round, although in subsequent rounds...
08:00 , Mar 5, 2007 |  BioCentury  |  Strategy

Trans-Atlantic play

Backed by a $175 million infusion from investors, EUSA Pharma Inc. says last week's acquisition of specialty pharma company OPi S.A. will provide revenues, products and infrastructure that will serve as the European foundation for...
08:00 , Dec 4, 2006 |  BioCentury  |  Politics, Policy & Law

Expanding the French model

French efforts to put state-backed capital into innovator companies look to be gaining legs, as the European Commission has opened the door for funding schemes that could be copied in other EU countries. Last month,...
07:00 , Oct 17, 2005 |  BioCentury  |  Finance

Ebb & Flow

Germany's Jerini has been tipped as a potential European IPO for more than a year, but the company has always maintained that it would go when the climate was right. The company has decided that...
07:00 , Aug 8, 2005 |  BioCentury  |  Product Development

Corporate Profile

IntegraGen S.A. Evry, France Technology: GenomeHIP (Genome Hybrid Identity Profiling) Disease focus: Endocrine, neurology Clinical status: Market Founded: 2000 by Joerg Hager, Philippe Gesnouin, Peter Brooks, Anne Philippi, Nathalie Vionnet University collaborators: Hopital Hotel-Dieu; Hopital...
03:24 , Feb 23, 2005 |  BC Extra  |  Financial News

Zealand raises EUR 13M

Zealand (Glostrup, Denmark) raised EUR 13 million ($17 million) in a second closing of its series C round, bringing to EUR 26 million ($34 million) the total raised. Investors in the second closing were CDC...